Study design: Prospective monocentric follow-up study. Objectives: To assess long-term functional and urodynamic results of augmentation enterocystoplasty in spinal cord injury (SCI) patients with detrusor hyperre¯exia and re¯ex incontinence who failed to respond to conservative treatment. Settings: Department of Urology (PitieÂ -SalpeÂ trieÁ re Hospital, Paris, France), Department of Neurological Rehabilitation (Raymond PoincareÂ Hospital, Garches, France), Assistance Publique ± Hopitaux de Paris, University Paris VI and V, France. Methods: Prospective study of 17 SCI patients (four above T6 level, nine between T6 and T12, and four below T12) with history of refractory urge incontinence to pharmacotherapy. Partial cystectomy (subtrigonal for 15) was performed with Hautmann enterocystoplasty (15) or detubularized clam cystoplasty (two). Results: Mean follow-up was 6.3+3.8 years (range 1.25 ± 10.5 years). Fifteen of 17 (88.5%) patients were completely continent under self clean intermittent catheterization (CIC) (mean 4.6/day, range 4 ± 7). The remaining two patients with pudendal nerve denervation had persistent stress urinary incontinence. No operative complications were noted. Long-term complications included recurrent pyelonephritis for one patient. Maximal cystometric capacity increased from 174.1+103.9 to 508.1+215.8 ml (P50.05). Maximal end ®lling pressure decreased from 65.5+50.2 to 18.3+7.9 cm H 2 O (P50.05). Conclusion: Urodynamic evaluation and clinical assessment demonstrate long-term success of augmentation enterocystoplasty in an homogeneous population (SCI) without delayed complications in SCI patients. Spinal Cord (2000) 38, 490 ± 494
Introduction
Safe urologic management of SCI patients should encompass maintenance of normal renal function. Key goals of urological management include maintenance of a low pressure bladder, avoiding high residual urine volume, free of pyelonephritis, and achieving urination. 1 ± 3 Clean intermittent catheterization (CIC) and parasympatholytic drugs are our method of choice to reach these goals. 4 ± 7 CIC may not be as eective if the bladder is hyperre¯exive with detrusor-sphincter dyssynergia. 4, 6 When CIC plus anticholinergic program failed to create an adequate bladder volume with lower pressure during storage, bladder augmentation is generally considered. 8 The purpose of this study is to assess the possibility of augmentation cystoplasty to achieve safe long-term urologic management in SCI patients.
Little is known about long-term results (over 5 years) in this speci®c population of patients. 9 We prospectively evaluated 17 SCI patients who underwent enterocystoplasty.
Materials and methods
From 1988 to 1998, 17 spinal cord injury patients were prospectively evaluated after augmentation ileocystoplasty. There were 11 men and six women. The levels of injury were above T6 level in four patients, nine patients between T6 and T12, and four patients below T12. Spinal cord injuries were related to trac crashes (n=16) and self injury in one. The average duration of SCI was 7.5 years (range 2 ± 16 years). Complete spinal Relevant past medical history in the patient population included a sphincterotomy in two male patients and unilateral nephrectomy for chronic re¯ux and recurrent pyelonephritis in three patients (Table 1) .
Among the 17 patients, 15 performed CIC (up to 10 times a day) but suered refractory urge incontinence despite a maximum of two anticholinergic drugs pharmacotherapy. One other patient had incontinence despite indwelling urethral catheter because of failure of CIC plus anticholinergic drugs. The last one had a bilateral ureterostomy for a post-traumatic infected pelvic hematoma and prostato-rectal ®stula. He asked for urinary reconstruction 12 months after trauma.
The upper urinary tract was pre-operatively dilated in eight patients. Renal failure occurred in two of them: one (male) with past chronic evolution (preoperative creatinine level 5200 mmoles/l, creatinine clearance 45 ml/min) because of vesicoureteral re¯ux, the second (female) was ®rst referred to the department of urology for acute renal insuciency. It resolved with bilateral ureteral catheters without any acquired functional damage, waiting for secondary enterocystoplasty with bilateral ureteral reimplantation.
Pre-operative urodynamics evaluation
All patients underwent careful preoperative urodynamics assessment using ICS recommendations. A room temperature¯uid ®lling was used (50 mL/min). Twelve patients had a small hyperre¯ective blader (maximal cystometric capacity below 250 ml, ®ve with detrusor-sphincter dyssynergia). Five patients had a hyperre¯ective bladder with maximal cystometric capacity above 250 ml. All the patients had decreased bladder compliance (5to 10 ml/cm H 2 O) including patients with previous sphincterotomy. Maximal end ®lling pressure was 65.5+50.2 cm H 2 O. The average urethral closure pressures were 13.5 cm H 2 O for female (n=6) and 44 cm H 2 O for male (n=11) patients.
Surgical technique
All patients underwent a partial cystectomy, most of them subtrigonal (n=15): the bladder dome was sagitally opened and excised up to 2 cm from its base. A segment of recon®gured ileum was anastomosed to the remaining bladder base. Our ®rst two patients were operated on with a clamshell-detubularized cystoplasty involving 20 cm of ileum. For the subsequent 15 patients, we used 60 cm ileum that is located 25 ± 40 cm from the ileo-caecal valvule. The isolated ileal segment was detubularized into a`W' shape as described by the Hautmann 10 procedure. Five patients with high-grade vesicoureteral re¯ux underwent reimplantation following the LeDuc-Camey procedure. 11 An indwelling urethral catheter was used for 13 days.
One male patient had the additional implantation of a peri-prostatic cu of arti®cial urinary sphincter because of severe sphincteric insuciency, without implanting the remaining part of the device. One female patient had had a successful Burch colposuspension before surgery for mixed incontinence (Table  1) .
Follow-up
Urologic follow-up included visits at 1, 3, 6, 12 months and then yearly. It consisted of history and physical examination, laboratory evaluation, and neo-bladder (stone screening) and renal ultrasound (upper urinary tract dilatation screening). Cystometries were planned to be performed each year during the ®rst 5 years of follow-up, thereafter according to symptoms. Cystography was initially performed yearly when vesicoureteral re¯ux preexisted, and radionuclear renal scan was used for the patient with chronic renal failure. If normal it was replaced by a yearly renal ultrasound examination before and after CIC looking for upper urinary tract dilatation.
Data analysis
All values are presented as mean+SD. Statistical analysis was done using the Student's t-test. A probability level of less than 0.05 was considered signi®cant.
Results
The mean follow up was 6.3+3.8 years (range 1.25 ± 10.5 years). Fifteen of 17 (88.2%) patients reported a 7) . No patient reported postop urge incontinence. There was one case of traumatic catheterization in male with a prostatic urethra false passage 6 years post augmentation. It was successfully treated with a simple endoscopic prostatic incision.
The remaining two male patients had persistent severe stress urinary incontinence despite bladder augmentation. However, both of them had had damage and denervation of the external sphincter due to multiple pelvic fracture at the time of SCI. More surprising, the main feature that distinguished these two patients was the failure in performing CIC (lack of motivation) leading to no reoperation for a better continence.
Post-operative urodynamic results (n=17) are listed on Table 2 and compared to preoperative data. Maximal cystometric capacity increased by a mean of 191% while the maximal end ®lling pressure decreased by 72% (all dierences are statistically signi®cant, P50.05). Six patients had uninhibited contractions during ®lling phase, always below 40 cm H 2 O that were not correlated to any leakage during urodynamics study.
Serum creatinine remained unchanged, even for the patient bearing chronic renal failure. Neither anemia nor electrolyte abnormality was diagnosed. No kidney unit has been lost. Bacteriuria occurred in ®ve patients.
No other peri-operative and short-term complications related to surgery have been encountered. There was no death. No bowel obstruction appeared, two patients suered prolonged (47 days) ileus and hindgut inertia that spontaneously resolved. One acute pyelonephritis had to be treated at day 4 without any consequence (ureteral catheters were present). Mean hospital stay was 21 days, seven hospitalizations were longer than 30 days because of waiting for rehabilitation center placement.
Long-term complications included recurrent acute pyelonephritis for one female patient (at least one per year). These severe kidney infections led to recurrent hospitalizations and were related to a right neobladder to kidney re¯ux. She was non compliant with scheduled CIC and was doing the Crede maneuver most of the time. This patient was continent with a bladder capacity up to 1200 ml. She was planned to a future cutaneous diversion to prevent these episodes. Her creatinine level stayed stable and normal (95 mmol/l). The patient with arti®cial urinary sphincter (AUS) implanted (cu only) developed prosthesis infection and the AUS was explanted after 6 months. He remained continent despite pre-op urethral closure pressure 25 cm H 2 O and an open bladder neck on cystography.
No spontaneous rupture of bladder appeared during follow-up, nor lithiasis. No bowel dysfunction appeared after surgery and no patient complained diarrhea.
Discussion
Augmentation enterocystoplasty was successful for more than 6 years in 88% of our SCI population. Augmentation cystoplasty, when it was ®rst introduced, was thought to be unsafe for SCI patients. 12, 13 More recent data has established augmentation cystoplasty as a safe and eective procedure that can help 80% to 95% of patients achieving dryness and perineal protection and also protects the upper urinary tract.
14 Although augmentation is an eective surgery. To our knowledge, this ecacy has not yet been so well described with long-term results (45 years) in this very speci®c SCI population.
Worsening of bowel dysfunction may be a major complication of bladder reconstruction. 15, 16 Up to 29% of the patients who underwent bladder augmentation regretted having the procedure due to subsequent bowel symptoms: increased bowel frequency, looser consistency, needed more help for evacuation and increased incontinence episodes. 16, 17 Wood 18 reported recently a 16% rate of his population with distressing chronic diarrhea after enterocystoplasty. This dysfunction can be related to coecum use (reducing long-term absorptive function) and ileocecal valve resection, which can compromise gastrointestinal transit sites. None of our patients had bowel dysfunction after the ®rst post-operative month. As no modi®cation was made in the post-operative and intensive care unit management of patients, it appears to be probably related to the surgical technique (no use of right colon). We believe subtrigonal cystectomy at the time of bladder augmentation in SCI patients has to remove as much as possible pathologic bladder tissue. The goal of surgery is to obtain bladder enlargement for a low pressure and high capacity reservoir. Native tissue is unable to achieve this goal at time of surgery and a better result can be obtained with new and compliant tissue (bowel). Given this fact, quality of bladder tissue has to be assessed during surgery and can be preserved if thin and without any hypertrophy leading to a reduced length of bowel use. We succeeded in two patients with good functional results. The remaining part of the bladder could be a reason for anticholinergic drugs use in ®ve patients. This did not appear to be correlated to any urodynamic data regarding neo-bladder contractions and these drugs have been prescribed to achieve a better bladder capacity during catheterization. It has been shown that combined simultaneous bladder outlet procedure and augmentation cystoplasty satisfactorily achieve continence without additional complication, even if arti®cial urinary sphincter is implanted. 8,19 ± 22 We had two male patients who previously had a sphincterotomy and became continent up to 2 years after bladder augmentation without any other surgery for augmentation of outlet resistance. For the two patients who demonstrated obvious stress incontinence leakage, one underwent an undiversion, which is known to be associated with a higher complication rate, 23 and the other presented with complex pelvic trauma (bone fractures and bladder injury) in addition to the spinal cord trauma.
In SCI, we believe the augmentation cystoplasty is able to treat refractory urge incontinence related to bladder hyperre¯exia with concomitant upper urinary tract preservation. However this procedure is irreversible as are other surgical procedures, e.g. autoaugmentation 24, 25 and Brindley procedure. 26, 27 The sacral deaerentation and combined implantation of an anterior sacral root stimulator that he described is a validated alternative which can be considered for complete spinal cord injury patients only, specially if patients ask for suppression of SCIC which is achieved for more than 85% of implanted patients. Moreover sacral deaerentation strongly impaired sexual function. Functional results of auto-augmentation remains a controversial issue. 25 The more recent publication of StoÈ hrer et al 28 seems to be more optimistic regarding bladder capacity and the low morbidity. Nevertheless, as in augmentation ileo-cystoplasty, the use of this technique needs patients' cooperation for SCIC and indication for a bladder surgery still remains related to failure of conservative medical treatment (anticholinergic drugs).
There is a need for reversible and conservative alternative therapies. Some are under development and investigation such as intravesical vanilloid agents, 29 intrathecal clonidine 30, 31 or botulinum A-Toxin detrusor injections. 32, 33 These could be speci®c alternatives to all surgical techniques for the future.
Conclusion
In a speci®c population of SCI, augmentation enterocystoplasty demonstrates long-term (over 5 years) clinical and urodynamics results and ecacy. Associated medical treatments and surgical procedure were discussed. Results of future new and minimal invasive therapies will have to take these into account for comparison in terms of upper urinary tract protection and continence with CIC.
